Harald Husebye

Harald Husebye

Auto-generated profile, based on publicly available information

Harald Husebye

Centre of Molecular Inflammation Research, Department of Clinical Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2006 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
HHHarald Husebye
Harald Husebye
ØHØyvind Halaas
Øyvind Halaas
HSHarald Stenmark
Harald Stenmark
GTGro Tunheim
Gro Tunheim
ØSØystein Sandanger
Øystein Sandanger
TETerje Espevik
Terje Espevik
Immune responses are initiated when molecules of microbial origin are sensed by the Toll‐like receptors (TLRs). We now report the identification of essential molecular components for the trafficking of the lipopolysaccharide (LPS) receptor complex. LPS was endocytosed by a receptor‐mediated mechanism dependent on dynamin and clathrin and colocalized with TLR4 on early/sorting endosomes. TLR4 was ubiquitinated and associated with the ubiquitin‐binding endosomal sorting protein hepatocyte growth factor‐regulated tyrosine kinase substrate, Hrs. Inhibition of endocytosis and endosomal sorting increased LPS signaling. Finally, the LPS receptor complex was sorted to late endosomes/lysosomes for degradation and loading of associated antigens onto HLA class II molecules for presentation to CD4+ T cells. Our results show that endosomal trafficking of the LPS receptor complex is essential for signal termination and LPS‐associated antigen presentation, thus controlling both innate and adaptive immunity through TLR4.

1 October 2010 in Immunity
Verified
Journal Article
Closed access
HHHarald Husebye
Harald Husebye
MAMarie Hjelmseth Aune
Marie Hjelmseth Aune
JSJørgen Stenvik
Jørgen Stenvik
ESEivind Samstad
Eivind Samstad
FSFrode Skjeldal
Frode Skjeldal
TETerje Espevik
Terje Espevik

5 May 2008 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
NNNadra J. Nilsen
Nadra J. Nilsen
SDSusanne Deininger
Susanne Deininger
UNUnni Nonstad
Unni Nonstad
FSFrode Skjeldal
Frode Skjeldal
HHHarald Husebye
Harald Husebye
TETerje Espevik
Terje Espevik
Lipoteichoic acid (LTA) is a central inducer of inflammatory responses caused by Gram-positive bacteria, such as Staphylococcus aureus, via activation of TLR2. Localization of TLR2 in relation to its coreceptors may be important for function. This study explores the signaling, uptake, and trafficking pattern of LTA in relation to expression of TLR2 and its coreceptors CD36 and CD14 in human monocytes. We found TLR2 expressed in early endosomes, late endosomes/lysosomes, and in Rab-11-positive compartments but not in the Golgi apparatus or endoplasmic reticulum (ER). Rapid internalization of fluorescently labeled LTA was observed in human monocytes, colocalizing with markers for early and late endosomes, lysosomes, ER, and Golgi network. Blocking CD14 and CD36 with antibodies inhibited LTA binding and LTA-induced TNF release from monocytes, emphasizing an important role for both molecules as coreceptors for TLR2. Importantly, blocking CD36 did not affect TNF release induced by N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2R,S)-propyl]-(R)-cysteinyl-seryl-(lysyl)3-lysine or LPS. Expression of CD14 markedly enhanced LTA binding to the plasma membrane and also enhanced NF-κB activation. LTA internalization, but not NF-κB activation, was inhibited in Dynamin-I K44A dominant-negative transfectants, suggesting that LTA is internalized by receptor-mediated endocytosis but that internalization is not required for signaling. In fact, immobilizing LTA and thereby inhibiting internalization resulted in enhanced TNF release from monocytes. Our results suggest that LTA signaling preferentially occurs at the plasma membrane, is independent of internalization, and is facilitated by CD36 and CD14 as coreceptors for TLR2.

1 April 2002 in Plant Physiology
Verified
Journal Article
Open access
PDF file
HHHarald Husebye
Harald Husebye
SCSupachitra Chadchawan
Supachitra Chadchawan
PWPer Winge
Per Winge
OTOle P. Thangstad
Ole P. Thangstad
Atle BonesAtle Bones
Atle Bones
Thioglucoside glucohydrolase 1 (TGG1) is one of two known functional myrosinase enzymes in Arabidopsis. The enzyme catalyzes the hydrolysis of glucosinolates into compounds that are toxic to various microbes and herbivores. Transgenic Arabidopsis plants carrying β-glucuronidase and green fluorescent protein reporter genes fused to 0.5 or 2.5 kb of the TGG1 promoter region were used to study spatial promoter activity. Promoter activity was found to be highly specific and restricted to guard cells and distinct cells of the phloem. No promoter activity was detected in the root or seed. All guard cells show promoter activity. Positive phloem cells are distributed in a discontinuous pattern and occur more frequent in young tissues. Immunocytochemical localization of myrosinase in transverse and longitudinal sections of embedded material show that the TGG1 promoter activity reflects the position of the myrosinase enzyme. In the flower stalk, the myrosinase-containing phloem cells are located between phloem sieve elements and glucosinolate-rich S cells. Our results suggest a cellular separation of myrosinase enzyme and glucosinolate substrate, and that myrosinase is contained in distinct cells. We discuss the potential advantages of locating defense and communication systems to only a few specific cell types.

3 May 2009 in Nature Immunology
Verified
Journal Article
Closed access
EPEva M Palsson-McDermott
Eva M Palsson-McDermott
SDSarah Doyle
Sarah Doyle
AMAnne F McGettrick
Anne F McGettrick
MHMatthew Hardy
Matthew Hardy
HHHarald Husebye
Harald Husebye
Luke O'NeillLuke O'Neill
Luke O'Neill

1 February 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
NNNadra J. Nilsen
Nadra J. Nilsen
GVGregory I. Vladimer
Gregory I. Vladimer
JSJørgen Stenvik
Jørgen Stenvik
MOM. Pontus A. Orning
M. Pontus A. Orning
MZMaria V. Zeid-Kilani
Maria V. Zeid-Kilani
ELEgil Lien
Egil Lien
Toll-like receptors (TLRs) are involved in sensing invading microbes by host innate immunity. TLR2 recognizes bacterial lipoproteins/lipopeptides, and lipopolysaccharide activates TLR4. TLR2 and TLR4 signal via the Toll/interleukin-1 receptor adaptors MyD88 and MAL, leading to NF-κB activation. TLR4 also utilizes the adaptors TRAM and TRIF, resulting in activation of interferon regulatory factor (IRF) 3. Here, we report a new role for TRAM and TRIF in TLR2 regulation and signaling. Interestingly, we observed that TLR2-mediated induction of the chemokine Ccl5 was impaired in TRAM or TRIF deficient macrophages. Inhibition of endocytosis reduced Ccl5 release, and the data also suggested that TRAM and TLR2 co-localize in early endosomes, supporting the hypothesis that signaling may occur from an intracellular compartment. Ccl5 release following lipoprotein challenge additionally involved the kinase Tbk-1 and Irf3, as well as MyD88 and Irf1. Induction of Interferon-β and Ccl4 by lipoproteins was also partially impaired in cells lacking TRIF cells. Our results show a novel function of TRAM and TRIF in TLR2-mediated signal transduction, and the findings broaden our understanding of how Toll/interleukin-1 receptor adaptor proteins may participate in signaling downstream from TLR2. Background: Toll-like receptor 2 (TLR2) mediates innate immune responses by recognizing microbial components. Results: TLR2-mediated induction of the chemokines Ccl4 and Ccl5 and interferon-β is impaired in macrophages lacking the signaling molecules TRAM, TRIF, TBK-1, IRF1, and IRF3. Conclusion: The TRAM/TRIF pathway is involved in TLR2 signaling. Significance: TLR signaling pathways determine the immune response mounted against infectious organisms.